Black Diamond Therapeutics Inc Annual Shareholders Meeting Transcript
Hello and welcome to the 2026 Virtual Annual Meeting of Black Diamond Therapeutics, Inc. Please note that today's meeting is being recorded. Stockholders may submit questions by following the instructions on the Annual Meeting interface.
I would like to turn the meeting over to Mark Velleca, the Chair of the Annual Meeting.
Good morning, everyone. My name is Mark Velleca, President, CEO, and Chair of the Board of Directors of Black Diamond Therapeutics. The meeting is now called to order. I've asked Karen Yu of Goodwin Procter, our outside legal counsel, to record the minutes.
It is a pleasure to welcome our stockholders and visitors to the 2026 Annual Meeting of Stockholders, Black Diamond Therapeutics. This meeting is being held in accordance with the company's bylaws and Delaware law.
We are conducting the annual meeting virtually instead of in person in order to facilitate the attendance and participation of our stockholders
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

